arrow
M

Muktar Ibrahim

university hospital southampton nhs foundation trust
H指数:7
被引数:163

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reporting and interpretation of respiratory metagenomic results in clinical practice: a systematic review and consensus guidelines from the UK NHS Respiratory Metagenomics Network

临床实践中呼吸道宏基因组学结果的报告与解读:英国NHS呼吸道宏基因组学网络系统综述与共识指南

2026-11-030
OAAI
BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation

BPZE1疫苗接种诱导产生与人类鼻粘膜分泌性IgA反应相关的IL-17+和IL-22+ CD4+ T细胞:对致病性百日咳博德特菌定植的影响

2026-04-180
OAAI
Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study

安全性、定植动力学、传染性和保护性免疫相关性在接种了Bordetella pertussis的英国健康成年人中的研究:一项单中心、开放标签、1期、受控人体感染研究

2026-03-230
OAAI
Controlled Human Infection of Healthy Adults With Lyophilized Neisseria lactamica Induces Asymptomatic, Immunogenic Nasopharyngeal Carriage in the United Kingdom and Mali

用冷冻干燥的奈瑟氏乳球菌对健康成人进行可控人类感染在英国和马里诱导了无症状、免疫原性的鼻咽部携带

2026-01-010
OA
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis

活 attenuated 鼻内百日咳疫苗 BPZE1 在英国的有效性、免疫原性和安全性:一项采用毒力性 Bordetella pertussis 的受控人体感染模型进行的随机、安慰剂对照、2b 期试验

2025-12-010
OAAI
A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage

重组共生细菌在咽部运输过程中引发异源抗原特异性免疫反应

2021-07-077
OA